Measuring health outcomes for older people using the sage database

Canadian Journal on Aging

Volumn 19, Issue SUPPL. 2, 2000, Pages 67-86

  Gambassi, G ^a   Lapane, K L ^a   Sgadari, A ^a   Landi, F ^a   Mor, V ^a   Bernabei, R ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Administrative Database; Aged; Health Outcomes; Minimum Data Set; Nursing Home; Observational Studies; Pharmaco epidemiology

Indexed keywords

DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGED; ARTICLE; CONGESTIVE HEART FAILURE; DATA BASE; ELDERLY CARE; FEMALE; HEALTH CARE FINANCING; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; OUTCOMES RESEARCH; RESIDENTIAL CARE; RESIDENTIAL HOME;

EID: 0034486356     PISSN: 07149808     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0714980800013908     Document Type: Article

References (93)

1. Aging: A subject that must be at the top of world agendas
2. Medication use and the elderly: Current status and opportunities
3. Evidence based medicine: What it is and what it isn't. It's about integrating individual clinical expertise and the best external evidence
4. Why are randomised controlled trials important?
5. Evidence-Based Medicine. A new approach to teaching the practice of medicine
6. Evidence-based medicine gaining supporters
7. Randomized clinical trials: The worst kind of epidemiology?
8. Looking for the evidence in medicine
9. Problems in the evidence of evidence-based medicine
10. Evidence-based medicine: An incomplete method for informing treatment choices
11. Ethics and evidence based medicine
12. Grey zone of clinical practice: Some limits to evidence-based medicine
13. Medicine based evidence, a prerequisite for evidence based medicine
14. Eligibility of Alzheimer's disease clinic patients for clinical trials
15. Qualitative research and evidence based medicine
16. The exclusion of the elderly and women from clinical trials in acute myocardial infarction
17. Including elderly people in clinical trials
18. Exclusion of elderly people from clinical research: A descriptive study of published reports
19. Access to advances in cardiology
20. Evidence-based and evidence-biased medicine
21. Developing high quality clinical databases: The key to a new research paradigm
22. When to base clinical policies on observational versus randomized trial data
23. Developing improved observational methods for evaluating therapeutic effectiveness
24. Why we need observational studies to evaluate the effectiveness of health care
25. Common language
26. PACE-setting research
27. Inappropriate medication prescribing in skilled-nursing facilities
28. Inappropriate drug prescribing for the community-dwelling elderly
29. An overview of comprehensive geriatric assessment: Rationale, history, program models, basic components
30. Drug use in the nursing home
31. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update
32. The SAGE database: Introducing functional outcomes in geriatric pharmaco-epidemiology
33. Characteristics of the SAGE database: A new resource for research on outcomes in long-term care
34. Designing the national resident assessment instrument for nursing homes
35. Validity of diagnostic and drug data in standardized nursing home resident assessments: Potential for geriatric pharmacoepidemiology
36. Management of pain in elderly cancer patients
37. Prevalence, clinical correlates and treatment of hypertension in institutionalized elderly
38. Comorbidity and drug use in cognitively impaired elderly living in long-term care
39. Reliability estimates for the Minimum Data Set for Nursing Home Resident Assessment and care screening (MDS)
40. A commitment to change: Revision of the HCFA's RAI
41. Effort to establish the reliability of the RAI
42. The OBRA-87 nursing home regulations and implementation of the resident assessment instrument: Effects on process quality
43. Effect of the national resident assessment instrument on selected health conditions and problems
44. Changes in hospitalization associated with introducing the resident assessment instrument
45. Association of the Resident Assessment Instrument (RAI) with changes in function, cognition, and psychosocial status
46. MDS cognitive performance scale
47. The structure of social engagement among nursing home residents
48. Predictors of nursing home resident's participation in activity programs
49. Validity of the minimum data set for assessing nutritional status in nursing home residents
50. Predicting patient scores between the Functional Independence measure and the Minimum Data Set: Development and performance of a FIM-MDS "crosswalk"
51. Windows to their world: The effect of sensory impariments on social engagement and activity time in nursing home residents
52. Evaluating a national assessment strategy for urinary incontinence in nursing home residents: Reliability of the Minimum Data Set and validity of the Resident Assessment Protocol
53. Frailty and hospitalization of long-term stay nursing home residents
54. The MDS cognition scale: A valid instrument for identifying and staging nursing home residents with dementia using the Minimum Data Set
55. Validation of the Minimum Data Set Cognitive Performance Scale: Agreement with the Mini-Mental State Examination
56. Minimum Data Set Plus (MDS+) scores compared with scores from five rating scales
57. Refining a case-mix measure for nursing homes: Resource utilization groups (RUG-III)
58. Mental dysfunction and resource use in nursing homes
59. Nursing home special care units: Distribution by type, state and facility characteristics
60. The impact of market and organizational characteristics on nursing care facility service innovation: A resource dependency perspective
61. The area resource file: A brief look
62. National patterns of angiotensin-convetting enzyme inhibitor use in congestive heart failure
63. Heart failure between 1986 and 1994: Temporal trends in drug-prescribing practices, hospital readmissions, and survival at an academic medical center
64. Temporal trends in pharmacotherapy for congestive heart failure at an academic medical center: 1990-1995
65. Effects of enalapril on mortality in severe congestive heart failure
66. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
67. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure
68. Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states
69. Underutilization of evidence-based therapy in heart failure. An opportunity to deal a winning hand with ace up your sleeve
70. Hospital use and mortality among Medicare beneficiaries in Boston and New Haven
71. The geography of health care in the United States
72. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals
73. The demographic timebomb
74. The treatment of unrelated disorders in patients with chronic medical diseases
75. Improving the quality of long-term care
76. From outcomes research to disease management: A guide for the perplexed
77. Disease management
78. Effects of residence in Alzheimer disease special care units on functional outcomes
79. Developing and testing of nursing home quality indicators
80. Using administrative databases to evaluate long-term care
81. Outcomes-based quality improvement: Reducing the data collection burden
82. Should MDS data be used for research?
83. Maximizing the Minimum Data Set
84. Community institutional care for frail elderly people
85. Effects of systematic geriatric assessment
86. Research on aging: An agenda for all nations individually and collectively
87. Approaching cross-national comparisons of nursing home residents
88. Facility and area variation affecting the use of physical restraints in nursing homes
89. Variations in the utilization of coronary angiography for elderly patients with an acute myocardial infarction